Skip to main content
$4.52 $0.07 (1.6%)

04:00 PM EDT on 05/19/22

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

CAPS Rating: No stars

Current Price $4.52 Mkt Cap $174.3M
Open $4.38 P/E Ratio 0.00
Prev. Close $4.52 Div. (Yield) $0.00 (0.0%)
Daily Range $4.38 - $4.65 Volume 443,010
52-Wk Range $3.74 - $31.54 Avg. Daily Vol. 695,918

Caps

How do you think NASDAQ:ORMP will perform against the market?

Add Stock to CAPS Watchlist

All Players

27 Outperform
2 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ORMP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NHWeston102 (64.17)
Submitted March 22, 2021

ORMP has been rivetingly focused over the last decade on solving one of the holy grail dreams of diabetic medicine - the discovery of a safe, consistent oral insulin pill which will end the use of injectables. They are suddenly getting close. In… More

AndrewGreenBull (90.65)
Submitted January 09, 2014

With less than 10m in cash and no candidate in phase 3, ORMP's hype can't last long. The market cap should be back down to 100M. Just my 2 cents

NASDAQ:ORMP VS S&P 500 (SPY)

Fools bullish on NASDAQ:ORMP are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ORMP.

Recs

0
Member Avatar krsjuls911 (< 20) Submitted: 8/10/2021 8:15:02 AM : Outperform Start Price: $23.30 NASDAQ:ORMP Score: -68.57

Oral insulin

Recs

1
Member Avatar NHWeston102 (64.17) Submitted: 3/22/2021 11:33:07 AM : Outperform Start Price: $10.08 NASDAQ:ORMP Score: -54.36

ORMP has been rivetingly focused over the last decade on solving one of the holy grail dreams of diabetic medicine - the discovery of a safe, consistent oral insulin pill which will end the use of injectables. They are suddenly getting close. In addition, ORMP has an obesity treatment in the works. They are also partnering on a COVID vaccine, assuming (quite reasonably) that COVID, like the Flu (inFLUenza", remember?), require a seasonal "booster" long after the pandemic has subsided. They will eventually succeed, diabetics will be liberated from needle doses and all their complications, and ORMP will either make a barrel of profits or a company like Novo-Nordisk or Lilly will buy them up.

Recs

0
Member Avatar JB3NC (< 20) Submitted: 7/22/2020 1:26:09 PM : Outperform Start Price: $3.87 NASDAQ:ORMP Score: -3.91

Is in phase 3 testing of a oral insulin drug. I hate shots.

Leaderboard

Find the members with the highest scoring picks in ORMP.

Score Leader

midastouch017

midastouch017 (< 20) Score: +211.23

The Score Leader is the player with the highest score across all their picks in ORMP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kevrose31 77.39 1/10/2014 Underperform 1Y $24.39 -81.47% +111.68% +193.14 0 Comment
GabrielSevrs 35.47 6/8/2021 Underperform 3W $13.62 -66.81% -7.84% +58.97 0 Comment
Flashvictor < 20 7/16/2020 Outperform 5Y $3.52 +28.41% +21.76% +6.65 0 Comment
retiren20 < 20 7/30/2020 Outperform 1Y $3.77 +19.89% +20.96% -1.07 0 Comment
JB3NC < 20 7/28/2020 Outperform 5Y $3.87 +16.95% +20.85% -3.91 3 Comments
naylorj 68.49 1/26/2021 Outperform 1Y $5.80 -22.07% +1.03% -23.10 0 Comment
Eskilf 70.46 2/4/2020 Outperform 5Y $5.09 -11.20% +18.07% -29.27 0 Comment
DavidSobel < 20 4/22/2021 Outperform 5Y $8.50 -46.82% -6.37% -40.45 0 Comment
VetteNV < 20 2/2/2021 Outperform 3Y $7.78 -41.90% +2.56% -44.47 0 Comment
theblindhog 23.69 3/26/2021 Outperform 1Y $9.94 -54.53% -0.40% -54.13 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ORMP.